Skip to main content
Equibles

BARCLAYS PLC

Position in ANIK — Anika Therapeutics, Inc.

CIK 312069 LONDON, X0
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$765,426
-$2,029 QoQ
Shares Held
52,319
-1.2% QoQ
Ownership
0.391%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#40
of 134 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. ANIK ranks #25 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 2,302,737 $165,474,680
2 NBIX
Neurocrine Biosciences Inc
 324,807 $54,742,970
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,343,554 $45,519,608
4 UTHR
UNITED THERAPEUTICS Corp
 72,010 $39,017,177
5 VTRS
Viatris Inc
 2,437,004 $38,699,622
6 INDV
Indivior Pharmaceuticals, Inc.
 907,024 $37,215,193
7 HIMS
Hims & Hers Health, Inc.
 861,006 $29,851,076
8 ALKS
Alkermes plc.
 219,935 $11,524,592

All Filings in ANIK

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $765,426 52,319
2026-03-31 $767,455 52,928
2025-12-31 $677,562 70,506
2025-09-30 $301,495 32,074
2025-06-30 $374,425 35,390
2025-03-31 $421,005 28,011
2024-12-31 $572,100 34,757
2024-09-30 $806,800 32,664
2024-06-30 $496,721 19,610
2024-03-31 $707,491 27,854
2023-12-31 $857,137 37,826
2023-09-30 $498,631 26,765
2023-06-30 $637,964 24,556
2023-03-31 $590,712 20,568
2022-12-31 $739,200 24,973
2022-09-30 $602,448 25,313
2022-06-30 $101,376 4,542
2022-03-31 $292,456 11,647
2021-12-31 $675,252 18,846
2021-09-30 $538,511 12,653
2021-06-30 $389,003 8,986
2021-03-31 $1,123,234 27,537
2020-12-31 $1,074,019 23,730
2020-09-30 $1,039,581 29,375
2020-06-30 $923,554 24,478
2020-03-31 $408,757 14,139